Franklin Resources’s Kymera Therapeutics KYMR Stock Holding History

Franklin Resources’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.1M	Buy	515,050 +153,278	+42%	+$13.2M	0.01%	620
2026 Q1	$30.1M	Buy	361,772 +7,197	+2%	+$570K	0.01%	820
2025 Q4	$27.6M	Buy	354,575 +322,913	+1,020%	+$21.8M	0.01%	849
2025 Q3	$1.79M	Sell	31,662 -1,987	-6%	-$89.6K	﹤0.01%	1814
2025 Q2	$1.47M	Buy	33,649 +822	+3%	+$28.3K	﹤0.01%	1832
2025 Q1	$898K	Sell	32,827 -5,540	-14%	-$202K	﹤0.01%	2011
2024 Q4	$1.54M	Buy	38,367 +8,927	+30%	+$403K	﹤0.01%	1818
2024 Q3	$1.36M	Buy	29,440 +7,647	+35%	+$338K	﹤0.01%	1858
2024 Q2	$651K	Buy	+21,793	New	+$755K	﹤0.01%	2119

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Franklin Resources's KYMR Position: Q2 2026 in Review

Franklin Resources increased its Kymera Therapeutics (KYMR) stake by 42% in Q2 2026, buying an estimated $13.2M and bringing the position to 515,050 shares worth $59.1M. The position accounts for 0.01% of the portfolio, ranked #620.

Franklin Resources first reported a position in KYMR in Q2 2024 and has held it in 9 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Franklin Resources held 515,050 shares of Kymera Therapeutics worth $59.1M as of Q2 2026.
Franklin Resources bought 153,278 Kymera Therapeutics shares in Q2 2026, an estimated $13.2M.
Kymera Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #620 holding.
Franklin Resources first reported a position in Kymera Therapeutics in Q2 2024 and has held it in 9 quarters since.
275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.